SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission
- PMID: 35211720
- PMCID: PMC8921607
- DOI: 10.1093/bib/bbac030
SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission
Abstract
Whole genome sequencing (WGS) can provide insight into drug-resistance, transmission chains and the identification of outbreaks, but data analysis remains an obstacle to its routine clinical use. Although several drug-resistance prediction tools have appeared, until now no website integrates drug-resistance prediction with strain genetic relationships and species identification of nontuberculous mycobacteria (NTM). We have established a free, function-rich, user-friendly online platform for MTB WGS data analysis (SAM-TB, http://samtb.szmbzx.com) that integrates drug-resistance prediction for 17 antituberculosis drugs, detection of variants, analysis of genetic relationships and NTM species identification. The accuracy of SAM-TB in predicting drug-resistance was assessed using 3177 sequenced clinical isolates with results of phenotypic drug-susceptibility tests (pDST). Compared to pDST, the sensitivity of SAM-TB for detecting multidrug-resistant tuberculosis was 93.9% [95% confidence interval (CI) 92.6-95.1%] with specificity of 96.2% (95% CI 95.2-97.1%). SAM-TB also analyzes the genetic relationships between multiple strains by reconstructing phylogenetic trees and calculating pairwise single nucleotide polymorphism (SNP) distances to identify genomic clusters. The incorporated mlstverse software identifies NTM species with an accuracy of 98.2% and Kraken2 software can detect mixed MTB and NTM samples. SAM-TB also has the capacity to share both sequence data and analysis between users. SAM-TB is a multifunctional integrated website that uses WGS raw data to accurately predict antituberculosis drug-resistance profiles, analyze genetic relationships between multiple strains and identify NTM species and mixed samples containing both NTM and MTB. SAM-TB is a useful tool for guiding both treatment and epidemiological investigation.
Keywords: drug-resistant tuberculosis; drug-susceptibility testing; nontuberculous mycobacteria; transmission; whole genome sequencing.
© The Author(s) 2022. Published by Oxford University Press.
Figures
Similar articles
-
Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.Int J Med Microbiol. 2020 Feb;310(2):151399. doi: 10.1016/j.ijmm.2020.151399. Epub 2020 Jan 17. Int J Med Microbiol. 2020. PMID: 31980371
-
Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples.Microbiol Spectr. 2022 Oct 26;10(5):e0125222. doi: 10.1128/spectrum.01252-22. Epub 2022 Sep 14. Microbiol Spectr. 2022. PMID: 36102651 Free PMC article.
-
Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.Genome Med. 2019 Jun 24;11(1):41. doi: 10.1186/s13073-019-0650-x. Genome Med. 2019. PMID: 31234910 Free PMC article.
-
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Cochrane Database Syst Rev. 2014. PMID: 24448973 Free PMC article. Updated. Review.
-
Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.J Biomed Sci. 2020 Jun 17;27(1):74. doi: 10.1186/s12929-020-00667-6. J Biomed Sci. 2020. PMID: 32552732 Free PMC article. Review.
Cited by
-
Trends of Drug-Resistant Tuberculosis in an Urban and a Rural Area in China: A 10-Year Population-Based Molecular Epidemiological Study.Infect Drug Resist. 2024 Mar 8;17:919-926. doi: 10.2147/IDR.S436563. eCollection 2024. Infect Drug Resist. 2024. PMID: 38481653 Free PMC article.
-
TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations.BMC Genomics. 2024 Feb 12;25(1):167. doi: 10.1186/s12864-024-10066-y. BMC Genomics. 2024. PMID: 38347478 Free PMC article.
-
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.PLoS One. 2023 Dec 5;18(12):e0294670. doi: 10.1371/journal.pone.0294670. eCollection 2023. PLoS One. 2023. PMID: 38051742 Free PMC article.
-
Implications for TB control among migrants in large cities in China: A prospective population-based genomic epidemiology study in Shenzhen.Emerg Microbes Infect. 2023 Nov 22;13(1):2287119. doi: 10.1080/22221751.2023.2287119. Online ahead of print. Emerg Microbes Infect. 2023. PMID: 37990991 Free PMC article.
-
Genotypic and spatial analysis of transmission dynamics of tuberculosis in Shanghai, China: a 10-year prospective population-based surveillance study.Lancet Reg Health West Pac. 2023 Jun 29;38:100833. doi: 10.1016/j.lanwpc.2023.100833. eCollection 2023 Sep. Lancet Reg Health West Pac. 2023. PMID: 37790084 Free PMC article.
References
-
- Takiff HE, Feo O. Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. Lancet Infect Dis 2015;15(9):1077–90. - PubMed
